The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is $19.58. In 2022 the company made an earnings per share (EPS) of $16.86 an increase over its 2021 EPS that were of $14.34.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $19.10 | 13.3% |
2022 | $16.86 | 17.57% |
2021 | $14.34 | -16.38% |
2020 | $17.15 | -4.32% |
2019 | $17.92 | 2.05% |
2018 | $17.56 | 382.51% |
2017 | $3.64 | -74.52% |
2016 | $14.28 | 12.66% |
2015 | $12.68 | 34.9% |
2014 | $9.40 | 0.74% |
2013 | $9.33 | 20.36% |
2012 | $7.75 | 37.93% |
2011 | $5.62 | -15.77% |
2010 | $6.67 | 6.4% |
2009 | $6.27 | 19.84% |
2008 | $5.23 | 35% |
2007 | $3.88 | 12% |
2006 | $3.46 | -15.54% |
2005 | $4.10 | 59.14% |
2004 | $2.57 | 6.9% |
2003 | $2.41 | -289.13% |
2002 | -$1.27 | -186.79% |
2001 | $1.47 | -4.5% |
2000 | $1.54 | 4.72% |
1999 | $1.47 | 23.98% |
1998 | $1.18 | 40.16% |
1997 | $0.84 | 2.52% |
1996 | $0.82 |